Key Takeaways Trade tensions and modest market gains highlight the growing appeal of value investing strategies. STNE, CNC, CVS and PFE pass key metrics like low P/CF, PEG under 1 and strong Value Scores. Each stock shows earnings resilience, with positive surprises and varied performance over the past year.The second half of 2025 has kicked off on a cautious note. While U.S. stocks opened June in positive territory, geopolitical tensions, particularly between the United States and China, continue to cast ...

Alongside housing, individuals receive primary care, mental health and substance use support, employment guidance and more personal services to help rebuild their livesSACRAMENTO, Calif., June 3, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), awarded a $2.6 million grant to connect individuals exiting the criminal justice system in Sacramento County to services that support a successful reentry into the ...

Preventative services, social support, health education and more to improve care access, quality and outcomesSACRAMENTO, Calif., May 29, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a partnership investment of more than $7.2 million to expand healthcare services to underserved Californians through mobile health clinics. Centene Foundation (PRN ...

It’s not an easy job to find value stocks. Being aware of a company's key financial numbers, like earnings per share and sales growth, can help investors identify stocks that are trading for less than their actual worth. However, a proper analysis of the fundamentals with the help of a number of metrics is required to determine whether a stock is a good bargain or not. When narrowing down the list of undervalued stocks, price to earnings (P/E) and price to sales (P/S) are the first ratios that come to an in ...

At a glance, Centene (NYSE: CNC ) seems almost too good to be true. With a bargain valuation, healthy revenue and earnings growth, and a large membership base spanning across the country, it was difficult at first to understand what pieces of the puzzleI am a full-time data scientist by trade and I have a growing passion for utilizing data-driven analysis to identify stock picking opportunities for long-term generation of wealth. My goal is to build as large a nest egg as possible for my retirement and, eve ...

The 2025 Q1 earnings season is slowly winding down, with the majority of S&P 500 companies already delivering their results. The period has overall been positive, though commentary surrounding upcoming periods has largely dictated post-earnings moves amid elevated uncertainty stemming from tariff talks.Still, several companies – Netflix (NFLX) , Eaton (ETN) , and Centene (CNC) – knocked it out of the park, posting robust results that had shareholders pleased. Let’s take a closer look at each release for tho ...

Centene Corporation (CNC) is aided by a growing Medicaid membership, an aging U.S. population, contract wins, strategic acquisitions and a notable financial standing.CNC’s Zacks Rank & Price PerformanceCentene currently carries a Zacks Rank #2 (Buy).The stock has gained 7.3% in the past three months against the industry’s 22.1% decline. The Zacks Medical sector declined 9.9% and the S&P 500 composite decreased 1.3% in the same time frame.Image Source: Zacks Investment ResearchCentene’s Favorable Style Score ...

In value analysis, though price to earnings (P/E) and price to sales (P/S) are most preferred by investors, the underrated price-to-book ratio (P/B ratio) is also an easy-to-use valuation tool for identifying low-priced stocks with exceptional returns. The ratio is used to compare a stock’s market value/price to its book value.The P/B ratio is calculated as below:P/B ratio = market price per share/book value of equity per shareP/B ratio reflects how many times book value investors are ready to pay for a sha ...

Wall Street saw a strong rally on Monday, driven by renewed optimism over U.S.-China trade relations. A 90-day agreement between the two nations to reduce tariffs has rekindled hopes of easing global trade tensions. The United States will lower duties on Chinese imports from a steep 145% to 30%, while China has agreed to cut its retaliatory tariffs on American goods from 125% to 10%, signaling a shift from confrontation to cooperation.Markets responded positively, with the S&P 500 jumping 3.3% to settle at ...

Industry Overview - The healthcare industry has faced challenges in early 2025, including concerns over potential cuts to Medicare and Medicaid, as well as the impact of tariffs on supplies [1] - Despite these challenges, healthcare stocks have performed relatively well, with the Health Care Select Sector SPDR Fund (XLV) down less than 2% year-to-date, compared to the S&P 500's decline of nearly 3% [1] Company Analysis: Centene - Centene Corp. (CNC) has shown solid membership and revenue growth, primarily driven by its Medicaid services, which have helped it withstand market volatility [3][4] - For Q1 2025, Centene reported a 29% year-over-year increase in Marketplace membership and a 22% increase in Medicare membership, contributing to a 28% improvement in adjusted diluted earnings per share (EPS) and a 17% growth in premium and service revenue [4] - The company has reiterated its full-year guidance, indicating optimism for future performance [4] Company Analysis: Tenet Healthcare - Tenet Healthcare Corp. (THC) has received positive analyst ratings, with 13 Buy ratings and four Holds, following a strong Q1 2025 earnings report that exceeded EPS estimates by $1.25 per share, reflecting a year-over-year improvement of over 35% [6][7] - The company plans to invest $250 million annually in its Ambulatory segment and has opened six new centers in Q1 2025, which are expected to drive continued growth [8] - Tenet's share repurchase program and efforts to improve its balance sheet are anticipated to enhance shareholder value [8] Company Analysis: Encompass Health - Encompass Health Corp. (EHC) reported better-than-expected earnings, leading to increased price targets from analysts [10] - The company's shares have risen over 25% year-to-date, with expectations of 10% projected earnings growth in the near term [11]